SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1.13 |
| Enterprise Value ($M) | 2.33 |
| Book Value ($M) | 18.09 |
| Book Value / Share | -286.65 |
| Price / Book | 0.06 |
| NCAV ($M) | 5.30 |
| NCAV / Share | 365.38 |
| Price / NCAV | 0.21 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.85 |
| Return on Assets (ROA) | -1,478.71 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.24 |
| Current Ratio | 2.24 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 9.74 |
| Assets | 22.53 |
| Liabilities | 4.44 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| PHMMF – Pharma Mar, S.A. | PKTX – ProtoKinetix, Incorporated |
| PLPL – Plandaí Biotechnology, Inc. | PREDQ – Predictive Technology Group, Inc. |
| PRNAF – Alterity Therapeutics Limited |
Financial data and stock pages provided by
Fintel.io